The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Session information

Symposium

[S32] Foldamers: The future pioneered by structural diversity

Sun. Mar 27, 2022 4:00 PM - 6:00 PM [Room B] Conference Room 131+132 (Bldg. 1: 3F)

Organizer: Takashi Misawa (NIHS), Mizuki Watanabe (Faculty of Pharm. Sci., Hokkaido Univ.)

"Foldamer" is an artificial oligomeric molecule with a regular secondary or tertiary structure consisting a low molecular unit. To date, a variety of foldamers has been developed, and is expected as new functional materials because of its unique structural properties. Foldamer was vigorously studied mainly in the field of macromolecular chemistry and engineering, whereas, in the field of pharmaceutical sciences, it has not been well known. However, foldamers can be attractive molecules even in this field because they can be chemically synthesized like low-molecular-weight compounds, and these molecules can have multipoint molecular recognition, which is difficult for low-molecular-weight compounds. Foldamers can have potential not only as tools for chemical biology study but also as drug candidates that target protein–protein interactions. (Review: Nat. Rev. Drug Discov. 2021, 20, 309)).
In this symposium, we would like to discuss recent advances of foldamer research: the design of the monomer molecules constituting the foldamer, and the sequence, the conformation, and the functions of the foldamers. We would also talk about the application to foldamers in drug discovery, which are expected to become the modality of the next-generation medium-sized molecular drugs.

趣旨説明:三澤 隆史(国立衛研) (4:00 PM - 4:02 PM)

総括:渡邉 瑞貴(北大院薬) (5:57 PM - 6:00 PM)

×

Authentication

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

×

Please log in with your participant account.
» Participant Log In